Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1829-1834

  Di Nardo, Anna ^a,b   Braff, Marissa H ^a   Taylor, Kristen R ^a   Na, ChangRim ^a   Granstein, Richard D ^c   McInturff, Jamie E ^d   Krutzik, Stephan ^d   Modlin, Robert L ^d   Gallo, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYTOKINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MATURATION; CNLP GENE; CONTACT SENSITIZATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENE; GENE DELETION; INNATE IMMUNITY; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SKIN ALLERGY; T LYMPHOCYTE;

EID: 33846549311     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1829     Document Type: Article

References (35)

1. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
2. Lee, P. H., T. Ohtake, M. Zaiou, M. Murakami, J. A. Rudisill, K. H. Lin, and R. L. Gallo. 2005. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. USA 102: 3750-3755.
3. Salzman, N. H., D. Ghosh, K. M. Huttner, Y. Paterson, and C. L. Bevins. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526.
4. Elssner, A., M. Duncan, M. Gavrilin, and M. D. Wewers. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J. Immunol. 172: 4987-4994.
5. De, Y., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069-1074.
6. Yang, D., O. Chertov, and J. J. Oppenheim. 2001. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukocyte Biol. 69: 691-697.
7. Oppenheim, J. J., A. Biragyn, L. W. Kwak, and D. Yang. 2003. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 62(Suppl 2): ii17-ii21.
8. Niyonsaba, F., K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106: 20-26.
9. Niyonsaba, F., M. Hirata, H. Ogawa, and I. Nagaoka. 2003. Epithelial cell-derived antibacterial peptides human β-defensins and cathelicidin: multifunctional activities on mast cells. Curr. Drug Targets Inflamm. Allergy 2: 224-231.
10. Braff, M. H., M. A. Hawkins, A. D. Nardo, B. Lopez-Garcia, M. D. Howell, C. Wong, K. Lin, J. E. Streib, R. Dorschner, D. Y. Leung, and R. L. Gallo. 2005. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174: 4271-4278.
11. Mookherjee, N., K. L. Brown, D. M. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F. M. Roche, R. Mu, G. H. Doho, J. Pistolic, et al. 2006. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176: 2455-2464.
12. Cole, A. M., J. Shi, A. Ceccarelli, Y. H. Kim, A. Park, and T. Ganz. 2001. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97: 297-304.
13. Sorensen, O. E., P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
14. Grabbe, S., and T. Schwarz. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19: 37-44.
15. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
16. Montagna, D., R. Maccario, F. Locatelli, V. Rosti, Y. Yang, P. Farness, A. Moretta, P. Comoli, E. Montini, and A. Vitiello. 2001. Ex vivo priming for long-term maintenance of antileukemia human cylotoxic T cells suggests a general procedure for adoptive immunotherapy. Blood 98: 3359-3366.
17. Ding, W., S. Beissert, L. Deng, E. Miranda, C. Cassetty, K. Seiffert, K. L. Campton, Z. Yan, G. F. Murphy, J. A. Bluestone, and R. D. Granstein. 2003. Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis. J. Clin. Invest. 111: 1923-1931.
18. Seiffert, K., J. Hosoi, H. Torii, H. Ozawa, W. Ding, K. Campton, J. A. Wagner, and R. D. Granstein. 2002. Catecholamines inhibit the antigen-presenting capability of epidermal langerhans cells. J. Immunol. 168: 6128-6135.
19. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347: 1151-1160.
20. Taylor, K. R., J. M. Trowbridge, J. A. Rudisill, C. C. Termeer, J. C. Simon, and R. L. Gallo. 2004. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279: 17079-17084.
21. Bowdish, D. M., D. J. Davidson, D. P. Speert, and R. E. Hancock. 2004. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172: 3758-3765.
22. Kurosaka, K., Q. Chen, F. Yarovinsky, J. J. Oppenheim, and D. Yang. 2005. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174: 6257-6265.
23. Akashi, S., S. Saitoh, Y. Wakabayashi, T. Kikuchi, N. Takamura, Y. Nagai, Y. Kusumoto, K. Fukase, S. Kusumoto, Y. Adachi, et al. 2003. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198: 1035-1042.
24. Di Nardo, A., A. Vitiello, and R. L. Gallo. 2003. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170: 2274-2278.
25. Rosenberger, C. M., R. L. Gallo, and B. B. Finlay. 2004. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. USA 101: 2422-2427.
26. Setterblad, N., C. Roucard, C. Bocaccio, J. P. Abastado, D. Charron, and N. Mooney. 2003. Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells. J. Leukocyte Biol. 74: 40-48.
27. Laulagnier, K., C. Motta, S. Hamdi, S. Roy, F. Fauvelle, J. F. Pageaux, T. Kobayashi, J. P. Salles, B. Perret, C. Bonnerot, and M. Record. 2004. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J. 380: 161-171.
28. Jans, R., G. Atanasova, M. Jadot, and Y. Poumay. 2004. Cholesterol Depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38. J. Invest. Dermatol. 123: 564-573.
29. + NKT cells to initiate contact sensitivity in vivo. J. Immunol. 175: 6390-6401.
30. Campos, R. A., M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P. W. Askenase. 2003. Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198: 1785-1796.
31. Martin, S. F., J. C. Dudda, E. Bachtanian, S. Burghard, S. Liller, A. Lembo, C. Galanos, and M. Freudenberg. 2006. Natural mutations in IL-12Rb2 and TLR4 result in increase or loss of chemical-induced contact hypersensitivity responses. J. Invest. Dermatol. 126(Suppl. 3): s66.
32. Davidson, D. J., A. J. Currie, G. S. Reid, D. M. Bowdish, K. L. MacDonald, R. C. Ma, R. E. Hancock, and D. P. Speert. 2004. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172: 1146-1156.
33. phox. Proc. Natl. Acad. Sci. USA 93: 6014-6018.
34. James, P. E., M. Madhani, C. Ross, L. Klei, A. Barchowsky, and H. M. Swartz. 2003. Tissue hypoxia during bacterial sepsis is attenuated by PR-39, an antibacterial peptide. Adv. Exp. Med. Biol. 530: 645-652.
35. Putsep, K., G. Carlsson, H. G. Boman, and M. Andersson. 2002. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360: 1144-1149.